Involvement of p53 in the cytotoxic activity of the NAMPT inhibitor FK866 in myeloid leukemic cells

作者: Basant Kumar Thakur , Tino Dittrich , Prakash Chandra , Annette Becker , Wolfgang Kuehnau

DOI: 10.1002/IJC.27726

关键词:

摘要: FK866 is a specific inhibitor of NAMPT and induces apoptosis leukemic cells by depletion intracellular NAD+. Since up-regulation associated with several cases cancers, including leukemias, we asked whether in inhibition involves p53 pathway. We observed that induced reduced cell proliferation NB-4, OCI-AML3 MOLM-13 lines. In contrast, the leukemia lines, K-562 Kasumi, containing nonfunctional were relatively unaffected treatment. Importantly, direct sirtuins significantly viability Activation involved increased acetylation at lysine 382 subsequent increase expression p21 BAX. Further, knockdown attenuated effects on cycle arrest, which was partly decreased Our results suggest role pathway anti-leukemic effect FK866.

参考文章(49)
Ardeshir Hakam, Domenico Coppola, Marilyn M Bui, Rodney E Shackelford, Over-expression of nicotinamide phosphoribosyltransferase in ovarian cancers. International Journal of Clinical and Experimental Pathology. ,vol. 3, pp. 522- 527 ,(2010)
Michael A. Nichols, Yue Xiong, Christopher W. Jenkins, Yan Li, Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21 Oncogene. ,vol. 9, pp. 2261- 2268 ,(1994)
Wei Gu, Jianyuan Luo, Chris L. Brooks, Anatoly Y. Nikolaev, Muyang Li, Dynamics of the p53 Acetylation Pathway Reversible Protein Acetylation. ,vol. 259, pp. 197- 207 ,(2004) , 10.1002/0470862637.CH14
Todd Riley, Eduardo Sontag, Patricia Chen, Arnold Levine, Transcriptional control of human p53-regulated genes Nature Reviews Molecular Cell Biology. ,vol. 9, pp. 402- 412 ,(2008) , 10.1038/NRM2395
Mara Gallí, Frédéric Van Gool, Anthony Rongvaux, Fabienne Andris, Oberdan Leo, The Nicotinamide Phosphoribosyltransferase: A Molecular Link between Metabolism, Inflammation, and Cancer Cancer Research. ,vol. 70, pp. 8- 11 ,(2010) , 10.1158/0008-5472.CAN-09-2465
Anita Boyapati, Eiki Kanbe, Dong-Er Zhang, p53 alterations in myeloid leukemia. Acta Haematologica. ,vol. 111, pp. 100- 106 ,(2004) , 10.1159/000074489
J Füllgrabe, E Kavanagh, B Joseph, Histone onco-modifications. Oncogene. ,vol. 30, pp. 3391- 3403 ,(2011) , 10.1038/ONC.2011.121
Xiuwei Tang, Yucui Zhu, Lydia Han, Arianna L. Kim, Levy Kopelovich, David R. Bickers, Mohammad Athar, CP-31398 restores mutant p53 tumor suppressor function and inhibits UVB-induced skin carcinogenesis in mice Journal of Clinical Investigation. ,vol. 117, pp. 3753- 3764 ,(2007) , 10.1172/JCI32481
Shaday Michan, David Sinclair, Sirtuins in mammals: insights into their biological function Biochemical Journal. ,vol. 404, pp. 1- 13 ,(2007) , 10.1042/BJ20070140
Michele Cea, Debora Soncini, Floriana Fruscione, Lizzia Raffaghello, Anna Garuti, Laura Emionite, Eva Moran, Mirko Magnone, Gabriele Zoppoli, Daniele Reverberi, Irene Caffa, Annalisa Salis, Antonia Cagnetta, Micaela Bergamaschi, Salvatore Casciaro, Ivana Pierri, Gianluca Damonte, Filippo Ansaldi, Marco Gobbi, Vito Pistoia, Alberto Ballestrero, Franco Patrone, Santina Bruzzone, Alessio Nencioni, Synergistic Interactions between HDAC and Sirtuin Inhibitors in Human Leukemia Cells PLoS ONE. ,vol. 6, pp. e22739- 366 ,(2011) , 10.1371/JOURNAL.PONE.0022739